Also known as: Senolytic Peptide
FOXO4-DRI is a peptide that plays a significant role in the field of anti-aging research. Its full name is Forkhead Box O4-Domain-Related Peptide Inhibitor, and it is primarily categorized under skin and anti-aging peptides. This peptide is designed to target and clear senescent cells, which are cells that have lost their ability to divide and contribute to aging and various age-related diseases.
FOXO4-DRI has garnered attention for its potential to rejuvenate tissues by selectively inducing apoptosis in these dysfunctional cells. This mechanism is crucial for maintaining cellular health and promoting longevity, making FOXO4-DRI a focal point in the study of aging and regenerative medicine.
FOXO4-DRI operates by binding to the FOXO4 protein, which is involved in regulating cellular senescence. By inhibiting FOXO4, the peptide promotes the death of senescent cells, thereby reducing their detrimental effects on surrounding healthy cells. This selective clearance helps restore tissue function and mitigate the aging process at a cellular level.
In summary, FOXO4-DRI is a promising peptide in the realm of anti-aging research, primarily known for its ability to clear senescent cells. Its mechanism of action and observed effects position it as a significant candidate for future studies aimed at enhancing longevity and tissue health.
Last updated: Feb 25, 2026